Study guide

14.2 Radiation Units, Radiobiology, and Health Effects

CIH Certified Industrial Hygienist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The CIH Exam and How to Use This Guide

1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan

2 Chapter 2: Basic Science & Calculations

2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals

3 Chapter 3: Air Sampling & Instrumentation

3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration

4 Chapter 4: Analytical Chemistry & Lab Methods

4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency

5 Chapter 5: Biostatistics & Epidemiology

5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection

6 Chapter 6: Toxicology & Biological Monitoring

6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring

7 Chapter 7: Biohazards & Indoor Environmental Quality

7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs

8 Chapter 8: Community Exposure & Environmental Health

8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know

9 Chapter 9: Health Risk Analysis & Hazard Communication

9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties

10 Chapter 10: Industrial Ventilation Principles & LEV Design

10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections

11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics

11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing

12 Chapter 12: Noise Measurement & Hearing Conservation

12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration

13 Chapter 13: Thermal Stress Assessment & Control

13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill

14 Chapter 14: Ionizing Radiation Protection

14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys

15 Chapter 15: Non-Ionizing Radiation & Laser Safety

15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance

16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment

16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control

17 Chapter 17: Ergonomics & Workstation Design

17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics

18 Chapter 18: Work Environments & Industrial Processes

18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation

19 Chapter 19: IH Program Management & Professional Ethics

19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement

14.2 Radiation Units, Radiobiology, and Health Effects

Key Takeaways Explain This Topic AI

Absorbed dose (gray or rad) is energy per unit mass; equivalent dose (sievert or rem) multiplies it by the radiation weighting factor; effective dose applies tissue weighting factors summing to 1.0 across the body.

Unit conversions are exam staples: 1 Gy = 100 rad, 1 Sv = 100 rem, and the radiation weighting factor is 1 for photons and beta, 20 for alpha, and 5 to 20 for neutrons by energy.

Stochastic effects (cancer, heritable effects) have no threshold and increase in probability with dose; deterministic tissue reactions (cataract, erythema, sterility) have a threshold and increase in severity above it.

Acute radiation syndrome progresses through hematopoietic, gastrointestinal, and neurovascular forms with increasing whole-body dose, each with a characteristic prodromal, latent, and manifest illness sequence.

Last updated: August 2026

Radiation Units, Radiobiology, and Health Effects

Once the physics of the radiation field is understood, the industrial hygienist has to convert it into dose to tissue and then into risk. That conversion runs through three different quantities — absorbed dose, equivalent dose, and effective dose — each with its own SI and conventional unit and its own weighting factor.

1. Radiation Quantities, Units, and Weighting Factors

Radiation measurements are defined across four distinct physical dimensions: source radioactivity, exposure in air, absorbed dose in matter, and biologically weighted equivalent/effective dose. +-------------------------------------------------------------------------------------------------+

  • | RADIATION MEASUREMENT FRAMEWORK |
  • | |
  • | [ Radioactivity ] --> Disintegrations per second (Ci, Bq) |
  • | │ |
  • | [ Exposure (Air) ] --> Ionization charge in dry air (Roentgen R, C/kg) |
  • | │ |
  • | [ Absorbed Dose (D) ] --> Energy deposited per unit mass (rad, Gray Gy: 1 Gy = 100 rad) |
  • | │ |
  • | ▼ × w_R (Radiation Weighting Factor: α=20, n=5-20, β/γ=1) |
  • | [ Equivalent Dose (H) ] -> H = D • w_R (rem, Sievert Sv: 1 Sv = 100 rem) |
  • | │ |
  • | ▼ × w_T (Tissue Weighting Factor: Gonads, Marrow, Lung, Thyroid) |
  • | [ Effective Dose (E) ] -> E = Σ (H_T • w_T) (Whole-body stochastic risk index) |
  • +-------------------------------------------------------------------------------------------------+
  • Comprehensive Unit Conversion Matrix

Quantity Physical Definition Traditional Unit SI Unit Exact Conversion Factor

Radioactivity (A) Disintegration rate of a radioactive source Curie (Ci) Becquerel (Bq) 1 Ci = 3.700 × 10¹⁰ Bq = 37 GBq; 1 Bq = 1 dps = 2.703 × 10⁻¹¹ Ci

Exposure (X) Total electric charge of ions produced in dry air (photons < 3 MeV) Roentgen (R) Coulomb / kilogram (C/kg) 1 R = 2.58 × 10⁻⁴ C/kg air; 1 C/kg = 3,876 R

Absorbed Dose (D) Mean energy imparted by ionizing radiation per unit mass of matter rad (radiation absorbed dose) Gray (Gy) 1 Gy = 1 J/kg = 100 rad; 1 rad = 100 erg/g = 0.01 Gy = 10 mGy

Equivalent Dose (H) Absorbed dose weighted for biological harm of specific radiation type rem (roentgen equivalent man) Sievert (Sv) 1 Sv = 1 J/kg = 100 rem; 1 rem = 0.01 Sv = 10 mSv = 1,000 mrem

Effective Dose (E) Sum of organ equivalent doses weighted for tissue radiosensitivity rem Sievert (Sv) 1 Sv = 100 rem; 1 rem = 10 mSv

Radiation Weighting Factors (wR / Quality Factor Q)

To account for differences in Relative Biological Effectiveness (RBE) resulting from ionization track density (Linear Energy Transfer, LET), absorbed dose is multiplied by a radiation weighting factor (wR): H = D × w R ( or H = D × Q ) \mathbf{H = D \times w_R} \quad (\text{or } H = D \times Q) H = D × w R ​ ( or H = D × Q )

  • Radiation Modality & Energy Range Radiation Weighting Factor (wR) Quality Factor (Q)
  • Photons (X-rays, Gamma rays, Bremsstrahlung) 1 1
  • Electrons, Positrons, Muons (Beta particles) 1 1
  • Protons and Charged Pions 2 2 to 5
  • Alpha Particles, Fission Fragments, Heavy Nuclei 20 20
  • Neutrons (Thermal, E < 10 keV) 5 2 to 5
  • Neutrons (Epithermal/Fast, 10 keV to 100 keV) 10 10
  • Neutrons (Fast, 100 keV to 2 MeV) 20 20
  • Neutrons (Fast, 2 MeV to 20 MeV) 10 10
  • Neutrons (E > 20 MeV) 5 5
  • Tissue Weighting Factors (wT) and Effective Dose (E)

Different human tissues and organs exhibit widely variable sensitivities to radiation-induced cancer induction and hereditary mutations. The Effective Dose (E) represents the uniform whole-body equivalent dose that carries the identical overall stochastic health risk: E = ∑ T H T × w T = ∑ T ( D T × w R ) × w T \mathbf{E = \sum_{T} H_T \times w_T = \sum_{T} \left( D_T \times w_R \right) \times w_T} E = T ∑ ​ H T ​ × w T ​ = T ∑ ​ ( D T ​ × w R ​ ) × w T ​

Where ΣT wT = 1.00.

  • Tissue / Organ ICRP 60 Weighting Factor (wT) ICRP 103 Weighting Factor (wT) Relative Radiosensitivity Category
  • Red Bone Marrow 0.12 0.12 High (Rapidly dividing hematopoietic stem cells)
  • Colon / Large Intestine 0.12 0.12 High (Rapid mucosal epithelial turnover)
  • Lung 0.12 0.12 High (Bronchial epithelium)
  • Stomach 0.12 0.12 High (Gastric mucosal lining)
  • Breast 0.05 0.12 High (Glandular epithelial tissue)
  • Gonads (Testes / Ovaries) 0.20 0.08 Moderate (Hereditary/germ cell mutagenesis)
  • Urinary Bladder 0.05 0.04 Moderate
  • Esophagus 0.05 0.04 Moderate
  • Liver 0.05 0.04 Moderate
  • Thyroid 0.05 0.04 Moderate (Concentrates radioiodines)
  • Bone Surface 0.01 0.01 Low
  • Skin 0.01 0.01 Low
  • Salivary Glands Remainder 0.01 Low
  • Brain Remainder 0.01 Low
  • Remainder Tissues (14 organs) 0.05 0.12 Combined somatic baseline
  • 2. Molecular Biophysics and Cellular Radiobiology

Ionizing radiation damages biological systems via two distinct biophysical pathways: +-------------------------------------------------------------------------------------------------+

  • | BIOLOGICAL DAMAGE PATHWAYS IN CELLULAR DNA |
  • | |
  • | 1. DIRECT ACTION (High-LET Dominant: Alpha, Heavy Recoil Nuclei): |
  • | Radiation Particle ── direct hit ──> DNA Phosphodiester Backbone ──> Complex DSB Cluster |
  • | |
  • | 2. INDIRECT ACTION (Low-LET Dominant: Gamma, X-ray, Beta): |
  • | Photon/Electron ──> Radiolysis of H₂O ──> Free Radicals (•OH, •H, e_aq⁻) ──> DNA Damage |
  • | |
  • | H₂O + hν ──> H₂O⁺• + e⁻ |
  • | H₂O⁺• + H₂O ──> H₃O⁺ + •OH (Hydroxyl Radical: Powerful Oxidizing Agent) |
  • | e⁻ + H₂O ──> e_aq⁻ (Hydrated Electron: Powerful Reducing Agent) |
  • +-------------------------------------------------------------------------------------------------+
  • Direct vs. Indirect Radiation Action

Direct Action: The primary ionizing particle directly strikes and ionizes the atomic structure of critical cellular targets (primarily double-stranded nuclear DNA). This is the dominant mechanism for high-LET radiation (alpha particles, neutrons). Direct action produces dense clusters of double-strand breaks (DSBs) that overwhelm cell repair enzymes, resulting in chromosomal aberrations or apoptotic cell death.

Indirect Action: The radiation interacts with ambient intracellular water molecules (which comprise ≈ 70 to 80% of cell mass), initiating radiolysis of water to generate highly reactive chemical species known as free radicals: H 2 O → h ν H 2 O + ∙ + e − ⟹ H 2 O + ∙ + H 2 O → H 3 O + + ∙ OH \text{H}_2\text{O} \xrightarrow{h\nu} \text{H}_2\text{O}^{+\bullet} + e^- \implies \text{H}_2\text{O}^{+\bullet} + \text{H}_2\text{O} \to \text{H}_3\text{O}^+ + \mathbf{^\bullet\text{OH}} H 2 ​ O h ν ​ H 2 ​ O +∙ + e − ⟹ H 2 ​ O +∙ + H 2 ​ O → H 3 ​ O + + ∙ OH The hydroxyl radical ((•)OH) is an aggressive oxidizing agent that diffuses short distances (≈ 2 to 4 nm) to chemically attack DNA bases and the sugar-phosphate backbone. Indirect action accounts for approximately 65% to 70% of total cellular damage caused by low-LET radiation (photons and beta particles).

Law of Bergonié and Tribondeau (1906)

The radiosensitivity of biological tissues is directly governed by cellular kinetics:

Cells are most radiosensitive when they possess a high mitotic rate (rapid cell division).

Cells are most radiosensitive when they have a long mitotic future (many future divisions scheduled).

Cells are most radiosensitive when they are undifferentiated (primitive stem cell morphology) . Radiosensitive Tissues: Erythroblasts, intestinal crypt cells, spermatogonia, basal skin cells, lymphocytes. Radioresistant Tissues: Mature neurons, myocytes (muscle cells), mature osteocytes, chondrocytes.

3. Stochastic Effects vs. Deterministic Tissue Reactions

Radiation-induced health effects are divided into two fundamentally distinct regulatory and biological classifications: +-------------------------------------------------------------------------------------------------+

  • | STOCHASTIC EFFECTS vs. DETERMINISTIC REACTIONS |
  • | |
  • | FEATURE STOCHASTIC EFFECTS DETERMINISTIC (TISSUE) REACTIONS |
  • | ─────────────────────────────────────────────────────────────────────────────────────────── |
  • | • Threshold NO THRESHOLD (Linear No-Thresh) CLEAR DOSE THRESHOLD |
  • | • Probability Proportional to dose (P ∝ Dose) Zero below threshold; 100% above |
  • | • Severity Independent of dose Increases with dose above threshold |
  • | • Primary Mechanism Sublethal DNA mutation Extensive cell killing / depletion |
  • | • Clinical Endpoints Carcinogenesis, Heritable traits Erythema, Cataracts, ARS, Epilation |
  • | • Protection Goal Keep exposures ALARA Prevent occurrence entirely by limits |
  • +-------------------------------------------------------------------------------------------------+
  • 1. Stochastic Effects (Probabilistic)

Physical Model: Governed by the Linear No-Threshold (LNT) hypothesis, which assumes that every increment of radiation dose, no matter how small, carries a proportional increase in cancer risk. There is no "safe" zero-risk threshold.

Risk Coefficients (ICRP 103): Nominal detriment-adjusted cancer risk coefficient is approximately 5.5 × 10⁻² Sv⁻¹ (5.5% per Sievert or 0.055% per rem) for the general public, and 4.1 × 10⁻² Sv⁻¹ for adult working populations.

Latency Period: Solid tumors have a clinical latency of 10 to 40+ years post-exposure; leukemias exhibit a shorter latency of 2 to 5 years .

2. Deterministic Effects (Tissue Reactions)

Deterministic effects result from acute or cumulative cell killing that exceeds the tissue's regenerative capacity. They do not occur below a specific physical threshold dose.

Clinical Tissue Endpoint Minimum Threshold Dose (Gy) Traditional Unit (rad) Clinical Progression & Pathology

Early Skin Erythema 2.0 to 3.0 Gy 200 to 300 rad Transitory capillary dilation and redness within 24 hours; main erythema phase at 2-3 weeks.

Temporary Epilation (Hair Loss) 3.0 Gy 300 rad Temporary loss of hair follicles with regrowth within 2-3 months.

Permanent Epilation 7.0 Gy 700 rad Complete destruction of follicular stem cells; permanent alopecia.

Dry Desquamation 8.0 to 12.0 Gy 800 to 1,200 rad Flaking, peeling, and hyperpigmentation of the epidermis.

Moist Desquamation / Necrosis > 15.0 Gy > 1,500 rad Complete destruction of basal germinal layer, bullae formation, ulceration, necrosis.

Ocular Cataractogenesis 0.5 Gy (ICRP 118) 50 rad Posterior subcapsular lens opacification. (Revised down from prior 2.0 Gy threshold).

Temporary Sterility (Males) 0.15 Gy 15 rad Oligospermia / azoospermia due to damage to dividing spermatogonia (t(1/2) ≈ 1 yr).

Permanent Sterility (Males) 3.5 to 6.0 Gy 350 to 600 rad Complete ablation of testicular germinal epithelium; Leydig cells remain intact.

Permanent Sterility (Females) 2.5 to 6.0 Gy 250 to 600 rad Oocyte destruction; threshold decreases with advancing maternal age.

4. Acute Radiation Syndrome (ARS)

Acute Radiation Syndrome (ARS) occurs following acute, high-dose whole-body or major partial-body exposure to penetrating ionizing radiation (> 0.7 Gy or 70 rad) delivered in a short time frame (typically minutes to hours). +-------------------------------------------------------------------------------------------------+

  • | FOUR CLINICAL PHASES OF ARS |
  • | |
  • | 1. PRODROMAL PHASE (Hours 0-48) --> Nausea, vomiting, diarrhea, fatigue, anorexia |
  • | 2. LATENT PHASE (Days 2-21) --> Apparent clinical recovery; stem cells depleting |
  • | 3. MANIFEST ILLNESS (Weeks 2-8) --> Severe syndrome crisis (infection, bleed, GI loss) |
  • | 4. RECOVERY OR DEATH (Months 1-12) --> Bone marrow reconstitution OR fatal organ collapse |
  • +-------------------------------------------------------------------------------------------------+
  • The Three Acute Clinical Syndromes

Syndrome Threshold Dose Latent Period Critical Target Organ & Pathophysiology Clinical Manifestations & Cause of Death

Hematopoietic (Bone Marrow) Syndrome 1.0 to 6.0 Gy (100--600 rad) 1 to 3 weeks Mitotic arrest of bone marrow multipotent stem cells causing profound pancytopenia (lymphopenia within 24h, followed by neutropenia and thrombocytopenia). Severe hemorrhage, petechiae, sepsis, overwhelming infection. LD(50/60) (lethal dose to 50% within 60 days without care) ≈ 3.5 to 4.5 Gy. With G-CSF, barrier isolation, and transfusions, survival extends up to ≈ 8 Gy.

Gastrointestinal (GI) Syndrome 6.0 to 20.0 Gy (600--2,000 rad) 3 to 5 days Complete destruction and mitotic arrest of intestinal crypt cells (stem cells) in the small bowel, leading to complete denudation of intestinal villi. Intractable watery/bloody diarrhea, massive fluid and electrolyte loss, septic shock from bacterial translocation across denuded intestinal barrier. Mortality ≈ 100% within 1 to 2 weeks.

Cerebrovascular / Central Nervous System (CNS) Syndrome > 20.0 to 50.0 Gy (> 2,000 rad) 0.5 to 3 hours Generalized breakdown of the blood-brain barrier, acute microvascular hyperpermeability, massive cerebral edema, increased intracranial pressure. Severe explosive nausea, ataxia, confusion, delirium, intractable seizures, cardiovascular shock, coma. 100% fatal within 24 to 72 hours.

  • 5. Worked Step-by-Step Calculation Examples
  • Worked Example 13.1: Radioactive Decay and Remaining Source Activity

Scenario: An industrial radiography camera contains an initial source activity of 80.0 Ci (2.96 TBq) of Iridium-192 (¹⁹²Ir, half-life t(1/2) = 73.83 days). Calculate the decay constant λ in day⁻¹ and determine the remaining source activity after exactly 120.0 days of field use.

Solution Steps:

Calculate the Radioactive Decay Constant (λ): λ = ln ⁡ ( 2 ) t 1 / 2 = 0.69315 73.83 days = 9.3885 × 10 − 3 day − 1 \lambda = \frac{\ln(2)}{t_{1/2}} = \frac{0.69315}{73.83\text{ days}} = 9.3885 \times 10^{-3}\text{ day}^{-1} λ = t 1/2 ​ ln ( 2 ) ​ = 73.83 days 0.69315 ​ = 9.3885 × 1 0 − 3 day − 1

Apply the Exponential Decay Equation: A ( t ) = A 0 e − λ t A(t) = A_0 e^{-\lambda t} A ( t ) = A 0 ​ e − λ t A ( 120 ) = 80.0 Ci × e − ( 9.3885 × 10 − 3 day − 1 × 120.0 days ) A(120) = 80.0\text{ Ci} \times e^{-(9.3885 \times 10^{-3}\text{ day}^{-1} \times 120.0\text{ days})} A ( 120 ) = 80.0 Ci × e − ( 9.3885 × 1 0 − 3 day − 1 × 120.0 days ) A ( 120 ) = 80.0 Ci × e − 1.12662 = 80.0 Ci × 0.32412 = 25.93 Ci A(120) = 80.0\text{ Ci} \times e^{-1.12662} = 80.0\text{ Ci} \times 0.32412 = 25.93\text{ Ci} A ( 120 ) = 80.0 Ci × e − 1.12662 = 80.0 Ci × 0.32412 = 25.93 Ci

Express in SI Units: A ( 120 ) = 25.93 Ci × 3.700 × 10 10 Bq/Ci = 9.594 × 10 11 Bq = 0.959 TBq A(120) = 25.93\text{ Ci} \times 3.700 \times 10^{10}\text{ Bq/Ci} = 9.594 \times 10^{11}\text{ Bq} = 0.959\text{ TBq} A ( 120 ) = 25.93 Ci × 3.700 × 1 0 10 Bq/Ci = 9.594 × 1 0 11 Bq = 0.959 TBq

Conclusion: The remaining source activity after 120 days is 25.9 Ci (959 GBq) .

Worked Example 13.2: Multiorgan Equivalent and Effective Dose Calculation

Scenario: During a nuclear incident, a clean-up technician receives the following organ-specific absorbed doses:

Lungs: Absorbed dose of 15.0 mGy from high-energy gamma rays (wR = 1) and 2.0 mGy from inhaled alpha particles (wR = 20).

Red Bone Marrow: Absorbed dose of 25.0 mGy from gamma rays (wR = 1) and 1.5 mGy from fast neutrons (wR = 20).

Gonads: Absorbed dose of 10.0 mGy from gamma rays (wR = 1).

Using ICRP 103 tissue weighting factors (w(T,lung) = 0.12, w(T,marrow) = 0.12, w(T,gonads) = 0.08), calculate:

The equivalent dose to the lungs (Hlung) and red bone marrow (Hmarrow).

The total effective dose contribution (Epartial) from these three irradiated organs.

Solution Steps:

Calculate Equivalent Dose to Lungs (Hlung): H lung = ∑ ( D i × w R , i ) = ( 15.0 mGy × 1 ) + ( 2.0 mGy × 20 ) = 15.0 mSv + 40.0 mSv = 55.0 mSv H_{\text{lung}} = \sum (D_i \times w_{R,i}) = (15.0\text{ mGy} \times 1) + (2.0\text{ mGy} \times 20) = 15.0\text{ mSv} + 40.0\text{ mSv} = 55.0\text{ mSv} H lung ​ = ∑ ( D i ​ × w R , i ​ ) = ( 15.0 mGy × 1 ) + ( 2.0 mGy × 20 ) = 15.0 mSv + 40.0 mSv = 55.0 mSv

Calculate Equivalent Dose to Red Bone Marrow (Hmarrow): H marrow = ( 25.0 mGy × 1 ) + ( 1.5 mGy × 20 ) = 25.0 mSv + 30.0 mSv = 55.0 mSv H_{\text{marrow}} = (25.0\text{ mGy} \times 1) + (1.5\text{ mGy} \times 20) = 25.0\text{ mSv} + 30.0\text{ mSv} = 55.0\text{ mSv} H marrow ​ = ( 25.0 mGy × 1 ) + ( 1.5 mGy × 20 ) = 25.0 mSv + 30.0 mSv = 55.0 mSv

Calculate Equivalent Dose to Gonads (Hgonads): H gonads = 10.0 mGy × 1 = 10.0 mSv H_{\text{gonads}} = 10.0\text{ mGy} \times 1 = 10.0\text{ mSv} H gonads ​ = 10.0 mGy × 1 = 10.0 mSv

Calculate Partial Effective Dose (Epartial): E partial = ( H lung × w T , lung ) + ( H marrow × w T , marrow ) + ( H gonads × w T , gonads ) E_{\text{partial}} = (H_{\text{lung}} \times w_{T,\text{lung}}) + (H_{\text{marrow}} \times w_{T,\text{marrow}}) + (H_{\text{gonads}} \times w_{T,\text{gonads}}) E partial ​ = ( H lung ​ × w T , lung ​ ) + ( H marrow ​ × w T , marrow ​ ) + ( H gonads ​ × w T , gonads ​ ) E partial = ( 55.0 mSv × 0.12 ) + ( 55.0 mSv × 0.12 ) + ( 10.0 mSv × 0.08 ) E_{\text{partial}} = (55.0\text{ mSv} \times 0.12) + (55.0\text{ mSv} \times 0.12) + (10.0\text{ mSv} \times 0.08) E partial ​ = ( 55.0 mSv × 0.12 ) + ( 55.0 mSv × 0.12 ) + ( 10.0 mSv × 0.08 ) E partial = 6.60 mSv + 6.60 mSv + 0.80 mSv = 14.0 mSv ( 1.40 rem ) E_{\text{partial}} = 6.60\text{ mSv} + 6.60\text{ mSv} + 0.80\text{ mSv} = 14.0\text{ mSv} \quad (1.40\text{ rem}) E partial ​ = 6.60 mSv + 6.60 mSv + 0.80 mSv = 14.0 mSv ( 1.40 rem )

Conclusion: The partial effective dose to the worker from these exposures is 14.0 mSv (1.40 rem) .